WEGO Health launches online video venture

Share this article:
WEGO Health is launching an ad-supported online video network, dubbed WEGOHealth.tv, that will feature “conversation-style videos” featuring its medical subject matter expert “health activists,” each of whom reaches an audience of more than 15,000 a month.

WEGOHealth.tv's beta incarnation, which went live today, features video channels on MS, joint pain, breast cancer and diabetes.

“We are taking these health activists off their keyboards and onto the airwaves to amplify their voices and reach an even greater audience,” said WEGO CEO Jack Barrette.

WEGO aims to capitalize on increasing consumer health engagement through use of video, citing a recent Pew Research Center study showing that a quarter of Internet users have watched an online video on health or medical issues. Seven in ten of WEGO's health activists watch online videos about health topics and they are four times more likely to create and upload their own health videos than the average online consumer, said the venture.

“Videos allow health activists and community leaders to really show the passion behind their message and connect with their audience in an even more personal way,” said WEGO health activist and ChronicBabe.com blogger Jenni Prokopy.

Paid advertising and content will be clearly marked, the company said, and all video editorial decisions will be independent of sponsor control.
Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.